|
30 Aug 2025 |
Jyothy Labs
|
Consensus Share Price Target
|
340.40 |
398.77 |
- |
17.15 |
buy
|
|
|
|
|
22 Aug 2025
|
Jyothy Labs
|
Geojit BNP Paribas
|
340.40
|
412.00
|
340.65
(-0.07%)
|
21.03 |
Buy
|
|
|
JLL delivered a modest Q1FY26 performance amid a challenging demand environ- Gross margin contracted 280bps YoY to 48.5%, due to input cost pressures and heightened competition in the Dish wash segment. EBITDA margin stood at 16.5%,...
|
|
13 Aug 2025
|
Jyothy Labs
|
Axis Direct
|
340.40
|
355.00
|
329.30
(3.37%)
|
4.29 |
Hold
|
|
|
Considering the near-term challenges, we have downgraded the stock from BUY to HOLD and revised our TP to Rs 355/share, implying an upside potential of 7% from the CMP.
|
|
13 Aug 2025
|
Jyothy Labs
|
ICICI Securities Limited
|
340.40
|
430.00
|
329.30
(3.37%)
|
26.32 |
Buy
|
|
|
JYL’s Q1FY26 performance was subdued with revenue/ volume growth of 1.4%/ 3.6% YoY impacted by heightened competitive intensity across segments.
|
|
27 May 2025
|
Jyothy Labs
|
Geojit BNP Paribas
|
340.40
|
404.00
|
341.50
(-0.32%)
|
18.68 |
Accumulate
|
|
|
|
|
21 May 2025
|
Jyothy Labs
|
Sharekhan
|
340.40
|
395.00
|
338.75
(0.49%)
|
16.04 |
Buy
|
|
|
Q4FY25 was yet another muted quarter for JLL amid subdued demand and higher competitive intensity hit revenue growth, while inflation in key input prices impacted profitability.
|
|
12 May 2025
|
Jyothy Labs
|
Motilal Oswal
|
340.40
|
375.00
|
350.80
(-2.96%)
|
Target met |
Neutral
|
|
|
Jyothy Laboratories (JYL) reported 1% YoY sales growth (below our est.) in 4QFY25. Volume growth was 4% (est. 7%, 8% in 3QFY25). The gap between volume and value growth was due to higher grammage and promotional price subs in select categories.
|
|
12 Apr 2025
|
Jyothy Labs
|
Axis Direct
|
340.40
|
405.00
|
371.50
(-8.37%)
|
18.98 |
Buy
|
|
|
We recommend a BUY with a near-term TP of Rs 405, implying an upside of 10% from the CMP.
|
|
11 Mar 2025
|
Jyothy Labs
|
Geojit BNP Paribas
|
340.40
|
395.00
|
333.90
(1.95%)
|
Target met |
Buy
|
|
|
|
|
01 Feb 2025
|
Jyothy Labs
|
Axis Direct
|
340.40
|
450.00
|
415.70
(-18.11%)
|
32.20 |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
31 Jan 2025
|
Jyothy Labs
|
Sharekhan
|
340.40
|
490.00
|
398.40
(-14.56%)
|
43.95 |
Buy
|
|
|
Jyothy Labs Limited’s (JLL’s) Q3FY25 performance was muted with revenue growing by just 4%, while a ~110 bps y-o-y decline in OPM led to 4% y-o-y decline in PAT.
|
|
04 Dec 2024
|
Jyothy Labs
|
Geojit BNP Paribas
|
340.40
|
496.00
|
411.15
(-17.21%)
|
45.71 |
Buy
|
|
|
|
|
13 Nov 2024
|
Jyothy Labs
|
Axis Direct
|
340.40
|
500.00
|
436.10
(-21.94%)
|
46.89 |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.
|
|
12 Nov 2024
|
Jyothy Labs
|
Sharekhan
|
340.40
|
575.00
|
441.35
(-22.87%)
|
68.92 |
Buy
|
|
|
Jyothy Labs Limited’s (JLL’s) Q2FY2025 performance was muted with revenue and PAT remaining flat y-o-y. OPM at 18.9% rose by 38 bps y-o-y.
|
|
12 Nov 2024
|
Jyothy Labs
|
Motilal Oswal
|
340.40
|
500.00
|
441.35
(-22.87%)
|
Target met |
Neutral
|
|
|
Jyothy Laboratories (JYL) reported flat sales YoY (miss) in 2QFY25. It posted a five-year CAGR of 10%. Volume growth was at 3%, on account of a high base.
|
|
13 Aug 2024
|
Jyothy Labs
|
Geojit BNP Paribas
|
340.40
|
645.00
|
548.10
(-37.89%)
|
|
Accumulate
|
|
|
|
|
26 Jul 2024
|
Jyothy Labs
|
Axis Direct
|
340.40
|
600.00
|
548.45
(-37.93%)
|
|
Buy
|
|
|
We maintain our long-term BUY rating on the stock.
|
|
25 Jul 2024
|
Jyothy Labs
|
ICICI Securities Limited
|
340.40
|
640.00
|
547.70
(-37.85%)
|
|
Buy
|
|
|
JYL’s Q1FY25 volume growth of 11% YoY is a material outperformance vs peers on a higher base as it continues to focus on direct distribution expansion, innovation, new SKUs coupled with continued investment behind the brands.
|
|
25 Jul 2024
|
Jyothy Labs
|
Motilal Oswal
|
340.40
|
565.00
|
547.70
(-37.85%)
|
Target met |
Neutral
|
|
|
Jyothy Laboratories (JYL) reported a revenue growth of 8% YoY (in line) in 1QFY25. It delivered a volume growth of 11% and continued to focus on volume-led growth to gain market share across categories.
|
|
25 Jul 2024
|
Jyothy Labs
|
Sharekhan
|
340.40
|
655.00
|
547.70
(-37.85%)
|
|
Buy
|
|
|
Jyothy Labs Limited’s (JLL’s) Q1FY2025 operating performance was in line with our expectation with revenues growing by 8% (versus expectation of 8.5%) while OPM stood at 18% (versus expectation of 17.9%).
|
|
29 May 2024
|
Jyothy Labs
|
Geojit BNP Paribas
|
340.40
|
478.00
|
413.25
(-17.63%)
|
Target met |
Accumulate
|
|
|
|